JP2008512117A5 - - Google Patents

Download PDF

Info

Publication number
JP2008512117A5
JP2008512117A5 JP2007531167A JP2007531167A JP2008512117A5 JP 2008512117 A5 JP2008512117 A5 JP 2008512117A5 JP 2007531167 A JP2007531167 A JP 2007531167A JP 2007531167 A JP2007531167 A JP 2007531167A JP 2008512117 A5 JP2008512117 A5 JP 2008512117A5
Authority
JP
Japan
Prior art keywords
amino acid
seq
domain
protein
fusion protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007531167A
Other languages
English (en)
Japanese (ja)
Other versions
JP4764881B2 (ja
JP2008512117A (ja
Filing date
Publication date
Priority claimed from US10/939,262 external-priority patent/US7807174B2/en
Application filed filed Critical
Publication of JP2008512117A publication Critical patent/JP2008512117A/ja
Publication of JP2008512117A5 publication Critical patent/JP2008512117A5/ja
Application granted granted Critical
Publication of JP4764881B2 publication Critical patent/JP4764881B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2007531167A 2004-09-10 2005-07-21 新規の治療タンパク質ベースの分子クラス Expired - Fee Related JP4764881B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/939,262 2004-09-10
US10/939,262 US7807174B2 (en) 2002-11-22 2004-09-10 Class of therapeutic protein based molecules
PCT/US2005/025831 WO2006031291A2 (en) 2004-09-10 2005-07-21 A novel class of therapeutic protein based molecules

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2010153231A Division JP5307082B2 (ja) 2004-09-10 2010-07-05 新規の治療タンパク質ベースの分子クラス

Publications (3)

Publication Number Publication Date
JP2008512117A JP2008512117A (ja) 2008-04-24
JP2008512117A5 true JP2008512117A5 (https=) 2009-12-17
JP4764881B2 JP4764881B2 (ja) 2011-09-07

Family

ID=36060467

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2007531167A Expired - Fee Related JP4764881B2 (ja) 2004-09-10 2005-07-21 新規の治療タンパク質ベースの分子クラス
JP2010153231A Expired - Fee Related JP5307082B2 (ja) 2004-09-10 2010-07-05 新規の治療タンパク質ベースの分子クラス

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2010153231A Expired - Fee Related JP5307082B2 (ja) 2004-09-10 2010-07-05 新規の治療タンパク質ベースの分子クラス

Country Status (16)

Country Link
US (2) US7807174B2 (https=)
EP (4) EP3530734A1 (https=)
JP (2) JP4764881B2 (https=)
KR (1) KR20070064619A (https=)
CN (2) CN104017787B (https=)
AU (1) AU2005285461B2 (https=)
BR (1) BRPI0515646B8 (https=)
CA (2) CA2823429C (https=)
DK (3) DK1786902T3 (https=)
ES (3) ES2554787T3 (https=)
IL (3) IL181779A (https=)
PT (3) PT3018204T (https=)
RU (1) RU2468080C2 (https=)
TR (1) TR201905393T4 (https=)
WO (1) WO2006031291A2 (https=)
ZA (1) ZA200702915B (https=)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100210528A1 (en) * 1999-03-05 2010-08-19 Leland Shapiro Compositions, methods and uses for inhibition and/or treatment of influenza infection
US8512710B2 (en) * 2002-11-22 2013-08-20 Ansun Biopharma, Inc. Class of therapeutic protein based molecules
US7807174B2 (en) * 2002-11-22 2010-10-05 Nexbio, Inc. Class of therapeutic protein based molecules
WO2004047735A2 (en) * 2002-11-22 2004-06-10 Mang Yu Broad spectrum anti-viral therapeutics and prophylaxis
WO2006051864A1 (ja) * 2004-11-10 2006-05-18 Hitachi Chemical Co., Ltd. 接着補助剤付金属箔及びそれを用いたプリント配線板
KR20080083266A (ko) * 2005-10-25 2008-09-17 엠엔디 다이어그노스틱 리미티드 인플루엔자 바이러스의 검출용 조성물 및 이를 이용한 키트및 방법
AU2015215955B2 (en) * 2006-01-24 2016-12-01 Ansun Biopharma, Inc. Technology for preparation of macromolecular microspheres
AU2013237761B8 (en) * 2006-01-24 2015-06-04 Ansun Biopharma, Inc. Technology for preparation of macromolecular microspheres
KR101501780B1 (ko) * 2006-01-24 2015-03-16 넥스바이오, 인코퍼레이티드 고분자 미소 구체들의 조제를 위한 기술
US8273381B1 (en) * 2006-04-14 2012-09-25 Auburn University Compositions for and methods of controlling olfactory responses to odorants
US20100143972A1 (en) * 2006-12-14 2010-06-10 Horswill Alexander R Method of Making Cyclic Polypeptides with Inteins
BRPI0807768A2 (pt) * 2007-02-20 2014-06-24 Dsm Ip Assests Bv Nova sialidase.
EP2178852B9 (en) 2007-08-03 2016-06-22 Romark Laboratories, L.C. Alkylsulfonyl-substituted thiazolide compounds
PE20121118A1 (es) * 2009-05-12 2012-09-05 Romark Lab Lc Compuestos de haloalquil heteroaril benzamida
AP2012006064A0 (en) * 2009-06-26 2012-02-29 Romark Lab Lc Compounds and methods for treating influenza.
US20110171718A1 (en) * 2009-07-31 2011-07-14 Danisco Us Inc. Proteases With Modified Pre-Pro Regions
JP2013510169A (ja) * 2009-11-06 2013-03-21 ネクスバイオ，インク． 呼吸器管の治療及び予防のための方法、化合物、及び組成物
US20130280332A1 (en) * 2012-02-17 2013-10-24 Nexbio, Inc. Methods, Compounds and Compositions for Treatment of Influenza and Parainfluenza Patients
EP2866792A4 (en) 2012-06-28 2016-08-17 Ansun Biopharma Inc MICROPARTICLE FORMULATIONS FOR DELIVERY TO LOWER AND CENTRAL RESPIRATORY PATHS AND METHOD OF PREPARING THEM
WO2014005107A2 (en) * 2012-06-28 2014-01-03 Ansun Biopharma, Inc. Microparticle formulations for delivery to the upper and central respiratory tract and methods of manufacture
CA3185756A1 (en) 2012-12-24 2014-07-03 Coagulant Therapeutics Corporation Short-acting factor vii polypeptides
EP2970857A4 (en) 2013-03-15 2016-11-02 Ansun Biopharma Inc NEW PROTEIN CLEANING PROCESS
PT3524617T (pt) 2013-03-15 2023-07-12 Gladiator Biosciences Inc Domínios gla como agentes terapêuticos
WO2014197485A1 (en) * 2013-06-03 2014-12-11 Ansun Biopharma, Inc. Anti-viral therapeutic for infection of the eye
US10300116B2 (en) 2013-06-10 2019-05-28 Ansun Biopharma, Inc. Treatment for BK polyomavirus infection
WO2014201027A2 (en) * 2013-06-10 2014-12-18 Ansun Biopharma, Inc. Treatment of merkel cell polyomavirus infection
WO2015184356A1 (en) 2014-05-30 2015-12-03 Ansun Biopharma, Inc. Treatment of middle east respiratory syndrome coronavirus
WO2016044656A1 (en) 2014-09-17 2016-03-24 Ansun Biopharma, Inc. Treatment of infection by human enterovirus d68
US9616114B1 (en) 2014-09-18 2017-04-11 David Gordon Bermudes Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity
WO2016115616A1 (en) * 2015-01-21 2016-07-28 Her Majesty The Queen In Right Of Canada As Represented By The Minister Of Health Inhibition of cellular proteases as treatment for influenza
US10676723B2 (en) 2015-05-11 2020-06-09 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
SG10202100652VA (en) 2015-07-21 2021-03-30 Univ Jefferson Gene therapies for neurodegenerative disorders targeting ganglioside biosynthetic pathways
ES2938890T3 (es) 2016-05-20 2023-04-17 Octapharma Ag Proteínas de fusión de VWF glucosiladas con farmacocinética mejorada
MX2018016393A (es) 2016-07-01 2019-08-12 Univ Leland Stanford Junior Conjugados para la edición de la superficie de la celula diana.
US11180535B1 (en) 2016-12-07 2021-11-23 David Gordon Bermudes Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
US11129906B1 (en) 2016-12-07 2021-09-28 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
DK3630968T3 (da) * 2017-05-26 2024-07-29 Genovis Ab Enzymer til glycananalyse
SG11202001535RA (en) * 2017-09-05 2020-03-30 Gladiator Biosciences Inc Method of targeting exosomes
KR102914621B1 (ko) 2018-01-03 2026-01-21 팔레온 파마슈티칼스 인크. 재조합 인간 시알리다제, 시알리다제 융합 단백질, 및 이를 사용하는 방법
GB201800274D0 (en) * 2018-01-08 2018-02-21 Enzymatica Ab Novel treatments
GB201803197D0 (en) 2018-02-27 2018-04-11 Pneumagen Ltd Viral treatment
WO2020018996A2 (en) * 2018-07-20 2020-01-23 Ansun Biopharma, Inc. Delivery of sialidase to cancer cells, immune cells and the tumor microenvironment
CN109991649B (zh) * 2019-03-26 2021-04-06 华中科技大学 一种制备无机闪烁体膜的方法
JP7343890B2 (ja) * 2019-04-26 2023-09-13 国立大学法人東海国立大学機構 シアリダーゼ活性を有する酵素剤及びその利用
CN110038122A (zh) * 2019-05-23 2019-07-23 武汉真福医药股份有限公司 枯草杆菌纤溶酶在治疗支气管炎药物中的应用
CA3145200A1 (en) 2019-07-03 2021-01-07 Aillis Inc. Pharmaceutical composition for treating influenza virus infections
CN111450236B (zh) * 2020-02-25 2023-04-07 西北大学 一种用于阻断冠状病毒感染的制剂
WO2021217053A1 (en) * 2020-04-24 2021-10-28 Rezolute, Inc. Plasma kallikrein inhibitors for the treatment of ards and related conditions
US20230218794A1 (en) * 2020-06-10 2023-07-13 The Penn State Research Foundation Process and system to lessen human coronavirus transmission and spread
WO2022147481A1 (en) 2020-12-30 2022-07-07 Ansun Biopharma Inc. Combination therapy of an oncolytic virus delivering a foreign antigen and an engineered immune cell expressing a chimeric receptor targeting the foreign antigen
CN117836432A (zh) * 2021-06-09 2024-04-05 微生物机器公司 用于检测患病细胞的工程化微生物

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3439089A (en) 1968-03-27 1969-04-15 Merck & Co Inc Medicated hard candy
US5643758A (en) 1987-03-10 1997-07-01 New England Biolabs, Inc. Production and purification of a protein fused to a binding protein
EP0286239B1 (en) * 1987-03-10 1996-03-13 New England Biolabs, Inc. Production and purification of a protein fused to a binding protein
RU2054180C1 (ru) 1991-08-21 1996-02-10 Жирнов Олег Петрович (н/п) Способ лечения вирусных респираторных инфекций
US5376633A (en) 1992-09-30 1994-12-27 Lezdey; John Method for deactivating viruses in blood component containers
US5985859A (en) * 1994-04-14 1999-11-16 The University Of Alabama Methods of inhibiting bacterial sialidase
BR9506262A (pt) * 1994-06-14 1997-08-12 Gist Brocades Bv Xilanase sequência de dna isolada e purificada vetor células hospedeira microbiana microorganismo isolado processos para a preparação de uma xilanase para a degradação de xilano para deslignificar pasta de madeira e produto obtido após o tratamento da pasta de madeira
BR9607098B8 (pt) * 1995-02-27 2014-11-18 Gilead Sciences Inc Composto e composição farmacêutica.
GB9513683D0 (en) * 1995-07-05 1995-09-06 Ciba Geigy Ag Products
AU5546898A (en) 1997-01-14 1998-08-07 Hopital Sainte-Justine Human lysosomal sialidase and therapeutic uses thereof
US6251392B1 (en) 1997-10-20 2001-06-26 Epicyte Pharmaceuticals, Inc. Epithelial cell targeting agent
US6737511B1 (en) 1999-08-16 2004-05-18 The United States Of America As Represented By The Department Of Health And Human Services Receptor-mediated uptake of an extracellular BCL-xL fusion protein inhibits apoptosis
US20020025320A1 (en) 1999-08-20 2002-02-28 Prosper Boyaka Sialidases as mucosal adjuvants
CN1405562A (zh) * 2002-10-24 2003-03-26 肖洪武 一种唾液酸酶测定试剂
US7807174B2 (en) * 2002-11-22 2010-10-05 Nexbio, Inc. Class of therapeutic protein based molecules
WO2004047735A2 (en) 2002-11-22 2004-06-10 Mang Yu Broad spectrum anti-viral therapeutics and prophylaxis
DE10258400A1 (de) * 2002-12-13 2004-06-24 N.V. Nutricia Trans-Sialidasen aus Trypanosoma congolense
KR101501780B1 (ko) 2006-01-24 2015-03-16 넥스바이오, 인코퍼레이티드 고분자 미소 구체들의 조제를 위한 기술

Similar Documents

Publication Publication Date Title
JP2008512117A5 (https=)
RU2007112502A (ru) Новый класс терапевтических белковых молекул
AU2008259768B2 (en) Compositions for delivering medicaments into the lungs, uses thereof
JP2021512899A5 (https=)
JP2010524849A5 (https=)
CN116033926A (zh) 针对ace2靶向病毒可用的结合蛋白
AU2015202864A1 (en) Fibronectin type III domain based scaffold compositions, methods and uses
CN113264990B (zh) 抑制新型冠状病毒(sars-cov-2)的多肽和其应用
JP2023029957A5 (https=)
JP2005512522A (ja) Ｉｌ−１３ムテインタンパク質、抗体、組成物、方法および使用
JP2014506450A5 (https=)
WO2024239980A1 (zh) 重组表达蛋白在预防/或治疗呼吸道疾病中的应用
JP2017529326A5 (https=)
AU2010306840A1 (en) Recombinant human CC10 protein for treatment of influenza
JP2025170319A (ja) Ｓａｒｓ－ｃｏｖ－２阻害剤
JP7009625B2 (ja) Ｈ３ｎ２亜型インフルエンザウイルスのヘマグルチニンタンパク質の突然変異体及びその使用
CN117186239A (zh) 融合蛋白及其应用
CN117050166B (zh) 中和呼吸道合胞病毒的c-型单域抗体及应用
TW202317600A (zh) 預防多種病毒感染的多價疫苗
WO2018231838A1 (en) Hydrochloride salts of c5a receptor agonist peptides
CN116782920A (zh) 用于治疗病毒感染的神经毡蛋白和血管紧张素转化酶2融合肽
HUE029250T2 (en) For use in the treatment of interferon-beta, influenza-induced lower respiratory diseases
WO2016200916A1 (en) Treatment of human metapneumovirus
JP2024041848A (ja) 新規な抗炎症性ペプチド及びその用途
CN105542003B (zh) 一种针对rsv粘附g蛋白表面抗原的全人源单克隆抗体